MedTrace Logo

Laser Therapy Following Radiotherapy for Gynecological Cancer

NCT03714581 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2019-07-30

No results posted yet for this study

Summary

Women with a history of pelvic radiotherapy due to gynecological cancer, will receive laser therapy for the management of genitourinary syndrome of menopause.

Conditions

  • Pelvic Radiotherapy
  • Gynecological Cancer
  • Dyspareunia
  • Vaginal Dryness

Interventions

DEVICE

Microablative Fractional CO2 Laser Therapy

5 laser therapies intravaginally administered will be applied at monthly intervals.

Sponsors & Collaborators

  • National and Kapodistrian University of Athens

    lead OTHER

Principal Investigators

  • Stavros Athanasiou, Associate Proffesor · National and Kapodistrian University of Athens, Greece

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-15
Primary Completion
2021-06-30
Completion
2021-06-30

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03714581 on ClinicalTrials.gov